Global Head of Fundamental Equity
Discover emerging opportunities
For investors focused on long-term investing with real diversification, EM exposure is critical.
• Insight
Equity outlook: From positive to perilous
The economic outlook has been thrown into uncertainty due to the Middle East conflict, but global equity investors should balance short-term risks against the opportunities offered by established long-term secular themes.
Authors
Head of Emerging Markets team
Top keywords
Summary
- Developed markets yet to feel full impact of Middle East conflict
- Emerging markets rally stalled for now
- Pharmaceutical growth outlook undervalued
After a full month of war in Iran and the wider Middle East, we appear further away from a resolution, and markets are responding accordingly. Our constructive view on equities for 2026 is in peril. Oil and refined product inventories in key locations are shrinking, LNG cargoes are subject to a bidding war as both Asia and Europe try to restock, while the impact on other commodity markets, like grains, fertilizer and aluminum, is yet to be fully felt. All this adds up to inflationary pressure, which obviously isn’t good for the global economy and equities.
It’s now a known known that you should stay invested through crises, conflict and shock. From a long-term perspective this is undeniable, but it’s also becoming reflexive behavior in markets. The dynamics this month have been remarkable, with the muscle memory of the rapid equity market snapback after ‘Liberation day’ this time last year still fresh. You can feel the desire to return to risk-on at every hint of a ceasefire.
We have to face reality though, and while we hope for off-ramps to materialize for all parties to bring a speedy end to this conflict, at the time of writing the US is still assembling ground forces in the Middle East, and attacks on vital infrastructure from different sides are becoming more frequent.
As long-term investors we have been working hard to protect our portfolios. Our significant established investments in the renewable energy sector have helped, while positioning in traditional energy segments in our global and European equities strategies have acted as partial hedges. Beyond seeking inflation protection, the secular themes we track are largely intact.
For example, the AI theme in both the US and China, where energy remains abundant, are still in our sights. Also, while the oil-price shock and recent USD strength have been a challenge for emerging markets, the long-term EM thesis remains valid, with strong macro fundamentals, lower debt and geopolitical optionality all worth investing in, as Wim-Hein Pals discusses in our EM outlook. Our Latin America analyst João Giesta writes about his findings from a recent visit to Argentina and Chile, while portfolio manager Richard Purkiss gives a fascinating perspective on the ongoing revolution in the pharmaceutical sector.
Let’s hope the conflict turns out to be short-lived and we have a more positive backdrop for equities by the start of the third quarter.
Emerging markets investing
Get the latest insights
Subscribe to our newsletter for investment updates and expert analysis.
Important information
THIS WEBSITE IS SOLELY INTENDED FOR PROFESSIONAL INVESTORS, WHICH HAS THE MEANING ASCRIBED TO IT IN THE SECURITIES AND FUTURES ORDINANCE (CAP. 571 OF THE LAWS OF HONG KONG) AND ITS SUBSIDIARY LEGISLATION. Investment involves risks. Past performance is not indicative of future performance. The information contained in this website is provided for reference only and does not constitute investment advice or an offer or solicitation to buy or sell in any securities or to adopt any investment strategy. Investors should not base their investment decisions solely on the information provided on this website and are advised to seek independent advice (including advice on tax implications) before making any investment decisions. Investors should ensure they fully understand the risks associated with the investment products and should also consider their own investment objectives and risk tolerance level. The investment decision is yours. You should not invest unless the intermediary who sells you the investment products has advised you that it is suitable for you and has explained how it is consistent with your investment objectives. Please refer to the relevant offering documents or other legal documents for further details including the risk factors. This website is published by Robeco Hong Kong Limited which is regulated by the Hong Kong Securities and Futures Commission (“SFC”) (CE No. APU851). This website has not been reviewed by the SFC. No assurance can be given that the investment objective of any investment products will be achieved. No representation or promise as to the performance of any investment products or the return on an investment is made. The value of investments may fluctuate. Past performance, projections, or forecasts included in this website should not be regarded as guarantees or indications of future performance, and no express or implied warranty is provided. The contents of this website are based on sources believed to be reliable, but due to the nature of information delivery technology and the necessity of using multiple data sources, including third party content, their accuracy is not guaranteed. The opinions expressed are as of the date shown above and may change as market conditions evolve, and are subject to change without notice. These opinions may differ from those of other Robeco investment professionals. Robeco accepts no liability for any direct, indirect, or consequential loss arising from the use of this material or any comments, opinions, or estimates contained herein. Robeco has no duty to update this website or any website content. Materials on this website may not be reproduced, distributed, or published without prior written permission from Robeco. Unless otherwise specified, Source: Robeco.
